CSRP3 Protein, Human (HEK293, His)

CSRP3 Protein, Human (HEK293, His) is the recombinant human-derived CSRP3 protein, expressed by HEK293, with C-6*His tag.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
  • Species: Human
  • Source: HEK293
  • 保管条件:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • 生物活性
  • Technical Parameters
  • Product Properties
  • ドキュメント
  • Help & FAQs

生物活性

製品説明

CSRP3 Protein, Human (HEK293, His) is the recombinant human-derived CSRP3 protein, expressed by HEK293, with C-6*His tag.

Background

CSRP3 is a positive regulator of myogenesis, acting as a cofactor for myogenic bHLH transcription factors such as MYOD1, and likely MYOG and MYF6. It enhances the DNA-binding activity of the MYOD1:TCF3 isoform E47 complex and may promote the formation of a functional MYOD1:TCF3 isoform E47:MEF2A complex involved in myogenesis (By similarity). In cardiomyocytes, CSRP3 plays a crucial and specific role in organizing cytosolic structures, potentially sensing mechanical stretch, and functioning as a scaffold protein to facilitate the assembly of interacting proteins at Z-line structures. It is essential for calcineurin anchorage to the Z line and required for stress-induced calcineurin-NFAT activation (By similarity). The role of CSRP3 in regulating cytoskeleton dynamics via interaction with CFL2 is controversially reported: it can enhance CFL2-mediated F-actin depolymerization depending on the CSRP3:CFL2 molecular ratio, but also reduces the ability of CLF1 and CFL2 to promote actin depolymerization. CSRP3 may maintain muscle cell integrity through an actin-based mechanism, directly binding to actin filaments, cross-linking them into non-polar bundles, and protecting them from dilution- and cofilin-mediated depolymerization (a function potentially involving self-association). In vitro, CSRP3 inhibits PKC/PRKCA activity and is proposed to modulate cardiac stress signaling by suppressing excessive PKC/PRKCA signaling (By similarity).

Technical Parameters

  • Species Human
  • Source HEK293
  • Tag C-6*His
  • アクセッション番号
  • 遺伝子ID
  • Molecular Construction
    • N-term
    • CSRP3 (M1-E194)
      Accession # P50461-1
    • 6*His
    • C-term
  • Protein Length

    Full Length of Isoform-1

  • 別名

    Cysteine and glycine-rich protein 3; CSRP3; Cysteine and glycine-rich protein 3

  • AA Sequence

    MPNWGGGAKCGACEKTVYHAEEIQCNGRSFHKTCFHCMACRKALDSTTVAAHESEIYCKVCYGRRYGPKGIGYGQGAGCLSTDTGEHLGLQFQQSPKPARSVTTSNPSKFTAKFGESEKCPRCGKSVYAAEKVMGGGKPWHKTCFRCAICGKSLESTNVTDKDGELYCKVCYAKNFGPTGIGFGGLTQQVEKKE

  • Predicted Molecular Mass

    21 kDa

  • 分子量

    Approximately 23 kDa, based on SDS-PAGE under reducing conditions.

  • 純度

    ≥ 95%, as determined by reducing SDS-PAGE.

    • Experimental Validation Results for CSRP3 Protein, Human (HEK293, His)
      ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

性状

Lyophilized powder.

Formulation

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 10% glycerol, 8% trehalose.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O.

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

輸送条件

Room temperature in continental US; may vary elsewhere.

Calculators

再構成計算機

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial)
=
Mass (in vial)
÷
Desired Reconstitution Concentration
希釈計算機

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)

濃度 (開始)
×
体積 (開始)
=
濃度 (終了)
×
体積 (終了)
比活性計算機
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50)
106 ÷
ng/mL